2025-10-21 13:37Press release

ImmuneBiotech stärker sin position – forskningsbaserad precisionsprobiotika lanseras på Apoteket AB

 
Bioteknikbolaget ImmuneBiotech Medical Sweden AB i Lund tar nästa steg i sin tillväxtresa när den forskningsbaserade precisionsprobiotikan GutMagnific® nu finns tillgänglig via Apoteket AB:s webbshop.
 
Produkten, utvecklad av ImmuneBiotechs egna forskare med över 20 års erfarenhet inom mikrobiomforskning, säljs sedan tidigare via bolagets egen webbutik. Lanseringen på Apoteket AB innebär en viktig bekräftelse på kvalitet, vetenskaplig grund och den växande efterfrågan på evidensbaserade hälsolösningar.
 
Länk till engelsk pressrelease:
 
För mer information, kontakta:
Dr. Shahram Lavasani, CEO
ImmuneBiotech Medical Sweden AB
s.lavasani@immunebiotech.com
+46 700 90 8946


About SmiLe Venture Hub – Pioneering Life Science and Foodtech Innovations

SmiLe is a leading venture hub that specializes in advancing life science and foodtech startups from concept to commercialization. We offer comprehensive support through every stage of entrepreneurship, including tailored incubation and acceleration programs, a variety of educational courses, and access to top-tier lab facilities. To date, our flagship incubator program has supported over 120 startups, facilitating their collective acquisition of more than EUR 1.16 billion in venture capital and contributing to 21 successful IPOs. Recognized as one of Europe’s leading startup hubs in 2024 by the Financial Times and Statista, SmiLe continues to be a catalyst for innovation in the life sciences sector. As a non-profit entity based in Lund, Sweden, SmiLe is supported by Region Skåne, Lund Municipality, Lund University, and Medicon Village. We are also backed by our partners Agilent, Sparbanken Skåne, Høiberg, Setterwalls, Zacco, Key2Compliance, Phase Holographic Imaging, ChemoMetec, Samplix, Qiagen, Merck, Bio-Rad, Zeiss, SmartStone Nordics, Säkra, Servier and AbbVie Scandinavia. For more information: www.smileventurehub.com